2013 Form 10-K Financial Statement
#000114420414019618 Filed on March 31, 2014
Income Statement
| Concept | 2013 | 2012 Q4 | 2012 |
|---|---|---|---|
| Revenue | $11.57M | $2.100M | $7.241M |
| YoY Change | 59.8% | -29.05% | -0.12% |
| Cost Of Revenue | $8.453M | $1.090M | $3.910M |
| YoY Change | 116.19% | 49.32% | 43.22% |
| Gross Profit | $3.118M | $1.010M | $6.650M |
| YoY Change | -53.11% | -54.71% | 47.12% |
| Gross Profit Margin | 26.95% | 48.1% | 91.83% |
| Selling, General & Admin | $17.21M | $3.650M | $15.43M |
| YoY Change | 11.54% | 82.5% | 94.33% |
| % of Gross Profit | 551.91% | 361.39% | 232.03% |
| Research & Development | $3.798M | $930.0K | $3.390M |
| YoY Change | 12.05% | -9400.0% | 3290.0% |
| % of Gross Profit | 121.81% | 92.08% | 50.98% |
| Depreciation & Amortization | $1.092M | $340.0K | $1.179M |
| YoY Change | -7.38% | 126.67% | 87.17% |
| % of Gross Profit | 35.02% | 33.66% | 17.73% |
| Operating Expenses | $21.21M | $4.630M | $19.02M |
| YoY Change | 11.53% | 132.66% | 136.57% |
| Operating Profit | -$18.10M | -$3.620M | -$12.37M |
| YoY Change | 46.28% | -1608.33% | 251.42% |
| Interest Expense | -$1.680M | -$190.0K | -$550.0K |
| YoY Change | 205.46% | -132.76% | -5.17% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$2.135M | -$20.00K | -$4.820M |
| YoY Change | -55.71% | -125.0% | -24200.0% |
| Pretax Income | -$20.23M | -$3.830M | -$19.78M |
| YoY Change | 2.27% | -525.56% | 466.76% |
| Income Tax | $18.59K | $0.00 | $20.00K |
| % Of Pretax Income | |||
| Net Earnings | -$20.25M | -$3.830M | -$19.81M |
| YoY Change | 2.21% | -572.84% | 413.21% |
| Net Earnings / Revenue | -174.99% | -182.38% | -273.57% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$0.20 | -$0.04 | -$0.24 |
| COMMON SHARES | |||
| Basic Shares Outstanding | |||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2013 | 2012 Q4 | 2012 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $3.290M | $2.620M | $2.620M |
| YoY Change | 25.57% | 16.44% | 16.44% |
| Cash & Equivalents | $2.616M | ||
| Short-Term Investments | |||
| Other Short-Term Assets | $1.630M | $73.67K | $920.0K |
| YoY Change | 77.17% | -91.72% | 3.37% |
| Inventory | $1.110M | $1.170M | $1.170M |
| Prepaid Expenses | |||
| Receivables | $2.430M | $1.090M | $1.090M |
| Other Receivables | $1.500M | $640.0K | $640.0K |
| Total Short-Term Assets | $9.950M | $6.447M | $6.450M |
| YoY Change | 54.26% | 24.95% | 25.0% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $920.0K | $2.440M | $2.440M |
| YoY Change | -62.3% | 149.26% | 148.98% |
| Goodwill | $1.129M | ||
| YoY Change | 59.66% | ||
| Intangibles | $34.14M | ||
| YoY Change | 1070.6% | ||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $480.0K | $180.0K | $180.0K |
| YoY Change | 166.67% | -43.75% | -43.75% |
| Total Long-Term Assets | $36.30M | $37.88M | $37.88M |
| YoY Change | -4.17% | 670.17% | 669.92% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $9.950M | $6.447M | $6.450M |
| Total Long-Term Assets | $36.30M | $37.88M | $37.88M |
| Total Assets | $46.25M | $44.33M | $44.33M |
| YoY Change | 4.33% | 339.86% | 339.78% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $3.350M | $1.434M | $1.430M |
| YoY Change | 134.27% | 21.54% | 21.19% |
| Accrued Expenses | $2.630M | $990.0K | $990.0K |
| YoY Change | 165.66% | 94.12% | 94.12% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $1.800M | $0.00 | $0.00 |
| YoY Change | |||
| Total Short-Term Liabilities | $10.56M | $2.812M | $2.810M |
| YoY Change | 275.8% | -10.37% | -10.51% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $3.820M | $2.560M | $2.560M |
| YoY Change | 49.22% | 10.34% | 10.34% |
| Other Long-Term Liabilities | $5.060M | $900.0K | $900.0K |
| YoY Change | 462.22% | -30.77% | -30.77% |
| Total Long-Term Liabilities | $8.880M | $3.460M | $3.460M |
| YoY Change | 156.65% | -4.42% | -4.42% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $10.56M | $2.812M | $2.810M |
| Total Long-Term Liabilities | $8.880M | $3.460M | $3.460M |
| Total Liabilities | $19.44M | $6.328M | $6.330M |
| YoY Change | 207.11% | -6.91% | -6.91% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$70.98M | ||
| YoY Change | 38.68% | ||
| Common Stock | $9.381K | ||
| YoY Change | 68.91% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $26.81M | $38.00M | $38.00M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $46.25M | $44.33M | $44.33M |
| YoY Change | 4.33% | 339.86% | 339.78% |
Cashflow Statement
| Concept | 2013 | 2012 Q4 | 2012 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$20.25M | -$3.830M | -$19.81M |
| YoY Change | 2.21% | -572.84% | 413.21% |
| Depreciation, Depletion And Amortization | $1.092M | $340.0K | $1.179M |
| YoY Change | -7.38% | 126.67% | 87.17% |
| Cash From Operating Activities | -$11.40M | -$4.160M | -$11.39M |
| YoY Change | 0.09% | 785.11% | 168.63% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $750.7K | -$350.0K | -$2.090M |
| YoY Change | -135.92% | 400.0% | 2885.71% |
| Acquisitions | $0.00 | -$24.56K | |
| YoY Change | -100.0% | ||
| Other Investing Activities | $2.140M | $140.0K | $500.0K |
| YoY Change | 328.0% | 455.56% | |
| Cash From Investing Activities | $1.390M | -$210.0K | -$1.590M |
| YoY Change | -187.42% | 250.0% | -8050.0% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $5.462M | $9.494M | |
| YoY Change | -42.47% | 314.58% | |
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 10.68M | 1.150M | 13.35M |
| YoY Change | -20.0% | -41.33% | 129.38% |
| NET CHANGE | |||
| Cash From Operating Activities | -11.40M | -4.160M | -11.39M |
| Cash From Investing Activities | 1.390M | -210.0K | -1.590M |
| Cash From Financing Activities | 10.68M | 1.150M | 13.35M |
| Net Change In Cash | 670.0K | -3.220M | 370.0K |
| YoY Change | 81.08% | -325.17% | -76.88% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$11.40M | -$4.160M | -$11.39M |
| Capital Expenditures | $750.7K | -$350.0K | -$2.090M |
| Free Cash Flow | -$12.15M | -$3.810M | -$9.300M |
| YoY Change | 30.65% | 852.5% | 123.02% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
360000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
360000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
360000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
340000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
0 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
0 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1420000 | USD |
| CY2012 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
289000 | USD |
| CY2013 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
324000 | USD |
| CY2013Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
3926681 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
1111507 | USD |
| CY2013Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
482349 | USD |
| CY2013Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
33768954 | USD |
| CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
1128517 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
46252280 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
740990 | USD |
| CY2013Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
1800000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10559662 | USD |
| CY2013Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
3620593 | USD |
| CY2013Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
316551 | USD |
| CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
6446773 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
9952991 | USD |
| CY2012Q4 | us-gaap |
Cash
Cash
|
2615805 | USD |
| CY2012Q4 | us-gaap |
Restricted Investments Current
RestrictedInvestmentsCurrent
|
53248 | USD |
| CY2013Q4 | us-gaap |
Restricted Investments Current
RestrictedInvestmentsCurrent
|
53257 | USD |
| CY2012Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
1733742 | USD |
| CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
1170097 | USD |
| CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
737445 | USD |
| CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1258282 | USD |
| CY2012Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
136436 | USD |
| CY2012Q4 | cmxi |
Property Plant And Equipments Net
PropertyPlantAndEquipmentsNet
|
2440081 | USD |
| CY2013Q4 | cmxi |
Property Plant And Equipments Net
PropertyPlantAndEquipmentsNet
|
919469 | USD |
| CY2012Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
180783 | USD |
| CY2012Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
34135287 | USD |
| CY2012Q4 | us-gaap |
Goodwill
Goodwill
|
1128517 | USD |
| CY2012Q4 | us-gaap |
Assets
Assets
|
44331441 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2812371 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
8018672 | USD |
| CY2012Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
0 | USD |
| CY2012Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
0 | USD |
| CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2812371 | USD |
| CY2012Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
2100000 | USD |
| CY2012Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
1441852 | USD |
| CY2012Q4 | cmxi |
Derivative Liabilities And Other Liabilities Noncurrent
DerivativeLiabilitiesAndOtherLiabilitiesNoncurrent
|
952344 | USD |
| CY2013Q4 | cmxi |
Derivative Liabilities And Other Liabilities Noncurrent
DerivativeLiabilitiesAndOtherLiabilitiesNoncurrent
|
3615521 | USD |
| CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
6327530 | USD |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
19440286 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012Q4 | us-gaap |
Temporary Equity Redemption Value
TemporaryEquityRedemptionValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Temporary Equity Redemption Value
TemporaryEquityRedemptionValue
|
500000 | USD |
| CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
9381 | USD |
| CY2013Q4 | cmxi |
Common Stock Issuable
CommonStockIssuable
|
432100 | USD |
| CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
108485646 | USD |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
10626 | USD |
| CY2012Q4 | cmxi |
Common Stock Issuable
CommonStockIssuable
|
489100 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
117097844 | USD |
| CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-70980216 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-91228576 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
38003911 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
26311994 | USD |
| CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
44331441 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
46252280 | USD |
| CY2013Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
909091 | shares |
| CY2013Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
909091 | shares |
| CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
93808386 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
107164855 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
93808386 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
107164855 | shares |
| CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <h2 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: bold 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> Use of Estimates</h2> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <h2 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: bold 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> Concentration of Risk</h2> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">Approximately $613,000 and $40,000 held in financial institutions was in excess of FDIC insurance at December 31, 2013 and 2012, respectively. Approximately $2,667,000 and $1,754,000 held in money market accounts at brokerage firms was in excess of Securities Investor Protection Corporation (“SIPC”) at December 31, 2013 and 2012, respectively. The amount not covered by SIPC is insured by the Company’s brokerage firm through additional “excess of SIPC” coverage from third party insurers. These third party insurers would cover losses in the event of the financial failure and liquidation of the financial institution that holds the Company’s institutional money market investments, however they do not insure against losses due to market fluctuations.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The Company currently has two commercially marketed products, both using PRP technology, that are presently marketed. Significant changes in technology could lead to new products or services that compete with the product offered by the Company. These changes could materially affect the price of the Company’s product or render it obsolete. The Company outsources manufacturing for all the components of its offerings.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">Company utilizes single suppliers for several components of the Angel and AutoloGel product lines. We outsource the manufacturing of various products, including component parts, composing the Angel line to contract manufacturers. While we believe these manufacturers to be of sufficient competency, quality, reliability, and stability, there is no assurance that one or more of them will not experience an interruption or inability to provide us with the products needed to satisfy customer demand. Additionally, while most of the components of AutoloGel are generally readily available on the open market, a reagent, bovine thrombin, is available exclusively through Pfizer, with whom the Company has an established vendor relationship.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2012 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
7241392 | USD |
| CY2013 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
10498726 | USD |
| CY2012 | us-gaap |
Licenses Revenue
LicensesRevenue
|
3154722 | USD |
| CY2013 | us-gaap |
Licenses Revenue
LicensesRevenue
|
167657 | USD |
| CY2012 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
168106 | USD |
| CY2013 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
703744 | USD |
| CY2012 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
0 | USD |
| CY2013 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
201311 | USD |
| CY2012 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
81859343 | shares |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3281583 | USD |
| CY2012 | cmxi |
Stock Redeemed Or Called During Period Value One
StockRedeemedOrCalledDuringPeriodValueOne
|
101569 | USD |
| CY2012 | cmxi |
Stock Redeemed Or Called During Period Value Two
StockRedeemedOrCalledDuringPeriodValueTwo
|
68416 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Preferred New Issues And Warrant Issued To Purchase Shares Of Common Stock One
StockIssuedDuringPeriodValuePreferredNewIssuesAndWarrantIssuedToPurchaseSharesOfCommonStockOne
|
1883765 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Conversion Of Convertible Securities Five
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesFive
|
1051371 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Conversion Of Convertible Securities One
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne
|
462000 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Conversion Of Convertible Securities Two
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo
|
34204548 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Conversion Of Convertible Securities Three
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesThree
|
924904 | USD |
| CY2013 | cmxi |
Stock Issued During Period Value Conversion Of Convertible Securities Three
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesThree
|
523927 | USD |
| CY2012 | cmxi |
Dividends Accrued On Preferred Stock One
DividendsAccruedOnPreferredStockOne
|
13562 | USD |
| CY2012 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
82500 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Long Term Incentive Plan
StockIssuedDuringPeriodValueLongTermIncentivePlan
|
15185 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Stock Warrants Exercised One
StockIssuedDuringPeriodValueStockWarrantsExercisedOne
|
584672 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Stock Warrants Exercised Two
StockIssuedDuringPeriodValueStockWarrantsExercisedTwo
|
213674 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Stock Warrants Exercised Three
StockIssuedDuringPeriodValueStockWarrantsExercisedThree
|
1521028 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Stock Guarantor Warrants Exercised One
StockIssuedDuringPeriodValueStockGuarantorWarrantsExercisedOne
|
715734 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Stock Warrants Exercised Four
StockIssuedDuringPeriodValueStockWarrantsExercisedFour
|
225001 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Stock Guarantor Warrants Exercised Two
StockIssuedDuringPeriodValueStockGuarantorWarrantsExercisedTwo
|
791667 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Pursuant To Private Offering
StockIssuedDuringPeriodValuePursuantToPrivateOffering
|
5000000 | USD |
| CY2013 | cmxi |
Stock Issued During Period Value Pursuant To Private Offering
StockIssuedDuringPeriodValuePursuantToPrivateOffering
|
4557188 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value Pursuant To Equity Purchase Agreement
StockIssuedDuringPeriodValuePursuantToEquityPurchaseAgreement
|
4493903 | USD |
| CY2013 | cmxi |
Stock Issued During Period Value Pursuant To Equity Purchase Agreement
StockIssuedDuringPeriodValuePursuantToEquityPurchaseAgreement
|
303000 | USD |
| CY2012 | cmxi |
Common Stock Issued Value In Lieu Of Cash For Consultant
CommonStockIssuedValueInLieuOfCashForConsultant
|
17850 | USD |
| CY2012 | cmxi |
Common Stock Issuable Value In Lieu Of Cash For Consultant
CommonStockIssuableValueInLieuOfCashForConsultant
|
17850 | USD |
| CY2012 | cmxi |
Common Stock Issuable Value To Holders Of Pre Bankruptcy Series Preferred Stock Pursuant To Reorganization Plan
CommonStockIssuableValueToHoldersOfPreBankruptcySeriesPreferredStockPursuantToReorganizationPlan
|
471250 | USD |
| CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1751107 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
676185 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value For Other Parties
StockIssuedDuringPeriodValueForOtherParties
|
275924 | USD |
| CY2013 | cmxi |
Stock Issued During Period Value For Other Parties
StockIssuedDuringPeriodValueForOtherParties
|
26678 | USD |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0063 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0077 | pure |
| CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y2M12D | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y10M24D | |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.29 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.34 | pure |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2012 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
39497770 | shares |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
61134957 | shares |
| CY2012 | cmxi |
Non Refundable Fees
NonRefundableFees
|
4500000 | USD |
| CY2013Q3 | us-gaap |
Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
|
150000 | USD |
| CY2012Q4 | us-gaap |
Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
|
780960 | USD |
| CY2013Q4 | us-gaap |
Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
|
1515540 | USD |
| CY2012Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
780960 | USD |
| CY2013Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
3248595 | USD |
| CY2011Q3 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
287000 | USD |
| CY2011Q4 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
287000 | USD |
| CY2013Q4 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
2250000 | USD |
| CY2013Q2 | us-gaap |
Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
|
53000 | USD |
| CY2013Q2 | cmxi |
Time Deposits Annual Interest Rate
TimeDepositsAnnualInterestRate
|
0.0010 | pure |
| CY2013Q2 | cmxi |
Time Deposits Maturity Date
TimeDepositsMaturityDate
|
2014-02-24 | |
| CY2012Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
1133400 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
2449199 | USD |
| CY2012Q4 | us-gaap |
Other Receivables Gross Current
OtherReceivablesGrossCurrent
|
643051 | USD |
| CY2013Q4 | us-gaap |
Other Receivables Gross Current
OtherReceivablesGrossCurrent
|
1493979 | USD |
| CY2012Q4 | cmxi |
Accounts And Other Receivables Gross Current
AccountsAndOtherReceivablesGrossCurrent
|
1776451 | USD |
| CY2013Q4 | cmxi |
Accounts And Other Receivables Gross Current
AccountsAndOtherReceivablesGrossCurrent
|
3943178 | USD |
| CY2012Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
42709 | USD |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
16497 | USD |
| CY2011Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
38233 | USD |
| CY2012Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
42709 | USD |
| CY2012 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
42625 | USD |
| CY2013 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
75166 | USD |
| CY2012 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
38149 | USD |
| CY2013 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
101378 | USD |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
16497 | USD |
| CY2012 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
602108 | USD |
| CY2012 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-654721 | USD |
| CY2012 | us-gaap |
Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
|
42625 | USD |
| CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-58590 | USD |
| CY2013 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
2182842 | USD |
| CY2012 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-3740 | USD |
| CY2012 | cmxi |
Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
|
-60105 | USD |
| CY2013 | us-gaap |
Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
|
75165 | USD |
| CY2012 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1179160 | USD |
| CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1092143 | USD |
| CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2047731 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
717863 | USD |
| CY2012 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
136436 | USD |
| CY2013 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
248606 | USD |
| CY2012 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
614450 | USD |
| CY2013 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
323146 | USD |
| CY2012 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
18000 | USD |
| CY2013 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
18589 | USD |
| CY2012 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-84336 | USD |
| CY2013 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
594173 | USD |
| CY2012 | cmxi |
Amendment To Contingent Consideration Effect On Income
AmendmentToContingentConsiderationEffectOnIncome
|
0 | USD |
| CY2013 | cmxi |
Amendment To Contingent Consideration Effect On Income
AmendmentToContingentConsiderationEffectOnIncome
|
1006159 | USD |
| CY2012 | us-gaap |
Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
|
0 | USD |
| CY2013 | us-gaap |
Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
|
-19868 | USD |
| CY2012 | cmxi |
Issuance Of Warrants Effect On Income
IssuanceOfWarrantsEffectOnIncome
|
0 | USD |
| CY2013 | cmxi |
Issuance Of Warrants Effect On Income
IssuanceOfWarrantsEffectOnIncome
|
303517 | USD |
| CY2012 | cmxi |
Adjustment To Conversion Price To Induce Conversion To Equity
AdjustmentToConversionPriceToInduceConversionToEquity
|
1513371 | USD |
| CY2013 | cmxi |
Adjustment To Conversion Price To Induce Conversion To Equity
AdjustmentToConversionPriceToInduceConversionToEquity
|
0 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
260510 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
2268104 | USD |
| CY2013 | cmxi |
Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
|
210153 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-83767 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
5206301 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
196953 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-11392819 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-11400996 | USD |
| CY2012 | cmxi |
Payments To Acquire Property Plant And Equipments
PaymentsToAcquirePropertyPlantAndEquipments
|
2087562 | USD |
| CY2013 | cmxi |
Payments To Acquire Property Plant And Equipments
PaymentsToAcquirePropertyPlantAndEquipments
|
750697 | USD |
| CY2012 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
-24563 | USD |
| CY2013 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD |
| CY2012 | us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
471289 | USD |
| CY2013 | us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
2139672 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-1591710 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
1388975 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
0 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
6240797 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
9493906 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
5462132 | USD |
| CY2012 | us-gaap |
Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
|
169986 | USD |
| CY2013 | us-gaap |
Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
|
0 | USD |
| CY2012 | cmxi |
Repayment Of Note Payable
RepaymentOfNotePayable
|
0 | USD |
| CY2013 | cmxi |
Repayment Of Note Payable
RepaymentOfNotePayable
|
1020000 | USD |
| CY2012 | cmxi |
Proceeds From Stock Option And Warrant Exercises
ProceedsFromStockOptionAndWarrantExercises
|
4066959 | USD |
| CY2013 | cmxi |
Proceeds From Stock Option And Warrant Exercises
ProceedsFromStockOptionAndWarrantExercises
|
0 | USD |
| CY2012 | us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
36595 | USD |
| CY2013 | us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
0 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
13354284 | USD |
| CY2012Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1374928 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1144095 | USD |
| CY2012 | cmxi |
Costs Of Goods Sold Depreciation
CostsOfGoodsSoldDepreciation
|
446000 | USD |
| CY2013 | cmxi |
Costs Of Goods Sold Depreciation
CostsOfGoodsSoldDepreciation
|
310000 | USD |
| CY2012 | cmxi |
Research Development Trials Studies Expenses
ResearchDevelopmentTrialsStudiesExpenses
|
287000 | USD |
| CY2013 | cmxi |
Research Development Trials Studies Expenses
ResearchDevelopmentTrialsStudiesExpenses
|
299000 | USD |
| CY2011Q4 | us-gaap |
Goodwill
Goodwill
|
706823 | USD |
| CY2013 | us-gaap |
Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
|
0 | USD |
| CY2012 | cmxi |
Adjustment Of Immaterial Measurement Period Change
AdjustmentOfImmaterialMeasurementPeriodChange
|
195132 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
10682929 | USD |
| CY2012 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
369755 | USD |
| CY2013 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
670908 | USD |
| CY2011Q4 | us-gaap |
Cash
Cash
|
2246050 | USD |
| CY2013Q4 | us-gaap |
Cash
Cash
|
3286713 | USD |
| CY2012Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
79090 | USD |
| CY2013Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
125583 | USD |
| CY2012Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1091007 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
985924 | USD |
| CY2012Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
61519 | USD |
| CY2013Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
63096 | USD |
| CY2012Q4 | cmxi |
Prepaid Fees And Rent For Services And Service Agreements
PrepaidFeesAndRentForServicesAndServiceAgreements
|
186407 | USD |
| CY2013Q4 | cmxi |
Prepaid Fees And Rent For Services And Service Agreements
PrepaidFeesAndRentForServicesAndServiceAgreements
|
151454 | USD |
| CY2012Q4 | us-gaap |
Deposit Assets
DepositAssets
|
409604 | USD |
| CY2013Q4 | us-gaap |
Deposit Assets
DepositAssets
|
279870 | USD |
| CY2012Q4 | us-gaap |
Prepaid Royalties
PrepaidRoyalties
|
6250 | USD |
| CY2013Q4 | us-gaap |
Prepaid Royalties
PrepaidRoyalties
|
724999 | USD |
| CY2012Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
73665 | USD |
| CY2013Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
38863 | USD |
| CY2013 | us-gaap |
Amortization Of Advance Royalty
AmortizationOfAdvanceRoyalty
|
100694 | USD |
| CY2012Q4 | cmxi |
Property Plant And Equipments Gross
PropertyPlantAndEquipmentsGross
|
3815009 | USD |
| CY2013Q4 | cmxi |
Property Plant And Equipments Gross
PropertyPlantAndEquipmentsGross
|
2063564 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
34958000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
34958000 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
822713 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1189046 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
|
366333 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
|
366333 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
|
366333 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
|
366333 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
|
299985 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
|
2418637 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1434166 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3351844 | USD |
| CY2012Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
833141 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
795584 | USD |
| CY2012Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
156205 | USD |
| CY2013Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
199634 | USD |
| CY2012Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
750 | USD |
| CY2013Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
2250 | USD |
| CY2012Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
388109 | USD |
| CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1873557 | USD |
| CY2013Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1800000 | USD |
| cmxi |
Proceeds From Conditional Grants
ProceedsFromConditionalGrants
|
30000 | USD | |
| CY2013Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
0.46 | |
| CY2013 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <h2 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: bold 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> Note 1 — Description of the Business</h2> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">Cytomedix, Inc. (“Cytomedix,” the “Company,” “we,” “us,” or “our”) is a regenerative therapies company marketing products within the U.S. and internationally. We commercialize innovative cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The use of autologous from self biological therapies for tissue repair and regeneration is part of a transformative clinical strategy designed to improve long term recovery in complex chronic conditions with significant unmet medical needs.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">Our current commercial offerings consist of point of care technologies for the safe and efficient separation of autologous blood and bone marrow to produce platelet based therapies or cell concentrates. Today, we have two distinct platelet rich plasma (“PRP”) devices, the AutoloGel<sup>TM</sup> System for wound care and the Angel® concentrated Platelet Rich Plasma (“cPRP”) System for orthopedics markets. Our sales are predominantly (approximately 91%) in the United States, where we sell our products through direct sales representatives and distributors. In 2013, Arthrex accounted for 48% of total product sales. Since August 8, 2013, Arthrex accounted for 100% of our Angel sales. This customer’s receivable balance at December 31, 2013 represented approximately 92% of the Company’s total accounts receivable. There were no other customers that represented a concentration in either revenue or receivables at December 31, 2013 or 2012.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">Growth drivers in the U.S. include Medicare coverage for the treatment of chronic wounds under a National Coverage Determination when registry data is collected under Coverage with Evidence Development (“CED”), and a worldwide distribution and licensing agreement that allows our partner to promote the Angel System for all uses other than wound care.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013Q4 | cmxi |
Deferred Licensing Revenue
DeferredLicensingRevenue
|
1844229 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
338613 | USD |
| CY2013 | cmxi |
Deferred Licensing Revenue Recognized Period
DeferredLicensingRevenueRecognizedPeriod
|
P5Y | |
| CY2012Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
780960 | USD |
| CY2013Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
3248595 | USD |
| CY2012Q4 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
58005 | USD |
| CY2013Q4 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
185405 | USD |
| CY2012Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
50000 | USD |
| CY2013Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
68589 | USD |
| CY2012Q4 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
33379 | USD |
| CY2013Q4 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
44194 | USD |
| CY2012Q4 | cmxi |
Conditional Grant Payable
ConditionalGrantPayable
|
30000 | USD |
| CY2013Q4 | cmxi |
Conditional Grant Payable
ConditionalGrantPayable
|
30000 | USD |
| CY2012Q4 | cmxi |
Term Loan Fee Payable Noncurrent
TermLoanFeePayableNoncurrent
|
0 | USD |
| CY2013Q4 | cmxi |
Term Loan Fee Payable Noncurrent
TermLoanFeePayableNoncurrent
|
38738 | USD |
| CY2013 | us-gaap |
Notes Issued1
NotesIssued1
|
500000 | USD |
| CY2013Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.46 | |
| CY2013 | us-gaap |
Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
|
(LIBOR), plus 8.0% | |
| CY2013 | cmxi |
Debt Instrument Description Of Floor Price
DebtInstrumentDescriptionOfFloorPrice
|
LIBOR floor of 3% | |
| CY2013 | cmxi |
Term Loan Fee Payable Percentage Year One
TermLoanFeePayablePercentageYearOne
|
0.05 | pure |
| CY2013 | cmxi |
Term Loan Fee Payable Percentage Year Two
TermLoanFeePayablePercentageYearTwo
|
0.03 | pure |
| CY2013 | cmxi |
Term Loan Fee Payable Percentage Thereafter
TermLoanFeePayablePercentageThereafter
|
0.01 | pure |
| CY2013 | cmxi |
Class Of Warrant Or Rights Issued To Lender
ClassOfWarrantOrRightsIssuedToLender
|
152000 | USD |
| CY2013 | cmxi |
Class Of Warrant Or Rights Issued To Guarantors
ClassOfWarrantOrRightsIssuedToGuarantors
|
304000 | USD |
| CY2013Q3 | cmxi |
Line Of Credit Facility Periodic Payment If Condition Satisfied
LineOfCreditFacilityPeriodicPaymentIfConditionSatisfied
|
125000 | USD |
| CY2013Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
7500000 | USD |
| CY2013Q1 | us-gaap |
Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
|
4500000 | USD |
| CY2013Q3 | cmxi |
Condition For Credit Facility
ConditionForCreditFacility
|
150000 | USD |
| CY2012 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2012 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2012 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
1267000 | USD |
| CY2013 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-212022 | USD |
| CY2012 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-653000 | USD |
| CY2013 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-401215 | USD |
| CY2012Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
4635000 | USD |
| CY2013Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
4243885 | USD |
| CY2012Q4 | us-gaap |
Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
|
5267000 | USD |
| CY2013Q4 | us-gaap |
Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
|
3649237 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
|
5087000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
|
5371000 | USD |
| CY2012Q4 | us-gaap |
Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
|
2512000 | USD |
| CY2013Q4 | us-gaap |
Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
|
2895000 | USD |
| CY2012Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
714000 | USD |
| CY2013Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
-3000 | USD |
| CY2012Q4 | cmxi |
Start Up And Organizational Costs
StartUpAndOrganizationalCosts
|
272000 | USD |
| CY2013Q4 | cmxi |
Start Up And Organizational Costs
StartUpAndOrganizationalCosts
|
272000 | USD |
| CY2012Q4 | cmxi |
Deferred Tax Assets Tax Deductible Goodwill
DeferredTaxAssetsTaxDeductibleGoodwill
|
136000 | USD |
| CY2013Q4 | cmxi |
Deferred Tax Assets Tax Deductible Goodwill
DeferredTaxAssetsTaxDeductibleGoodwill
|
112000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
244000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
240000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
|
522000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
|
-2000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
109000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1019000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
9596000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
9904000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
12353000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
12219000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
|
377000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
|
1088000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
50000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
69000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
|
-3184000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
|
-3472000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
41540000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
45458000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
|
38356000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
|
41986000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
38406000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
42055000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
-50000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
-69000 | USD |
| CY2012 | cmxi |
Deferred Tax Asset Purchase Accounting Changes
DeferredTaxAssetPurchaseAccountingChanges
|
13439000 | USD |
| CY2012 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
5267000 | USD |
| CY2013 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
3649000 | USD |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.350 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.350 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.042 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.044 | pure |
| CY2012 | cmxi |
Effective Tax Rate Reconciliation Fair Value Of Derivaives
EffectiveTaxRateReconciliationFairValueOfDerivaives
|
-0.068 | pure |
| CY2013 | cmxi |
Effective Tax Rate Reconciliation Fair Value Of Derivaives
EffectiveTaxRateReconciliationFairValueOfDerivaives
|
-0.029 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.037 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.009 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.019 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.055 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.265 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.180 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.001 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.001 | pure |
| CY2013Q4 | cmxi |
Deferred Tax Liability Provision For Income Tax
DeferredTaxLiabilityProvisionForIncomeTax
|
19000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
|
122389000 | USD |
| CY2013Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
6363638 | shares |
| CY2012Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
1.42 | |
| CY2013 | cmxi |
Stock Issued During Period Shares Issued In Registered Direct Offering
StockIssuedDuringPeriodSharesIssuedInRegisteredDirectOffering
|
9090911 | shares |
| CY2013Q1 | cmxi |
Warrants Exercise Price
WarrantsExercisePrice
|
0.75 | |
| CY2012 | cmxi |
Stock Issued During Period For Equity Purchase Agreement
StockIssuedDuringPeriodForEquityPurchaseAgreement
|
4350000 | shares |
| CY2013 | cmxi |
Stock Issued During Period For Equity Purchase Agreement
StockIssuedDuringPeriodForEquityPurchaseAgreement
|
450000 | shares |
| CY2013 | cmxi |
Stock Issued During Period For Equity Purchase Agreement One
StockIssuedDuringPeriodForEquityPurchaseAgreementOne
|
1500000 | shares |
| CY2013 | cmxi |
Stock Issued During Period For Fees Of Equity Purchase Agreement
StockIssuedDuringPeriodForFeesOfEquityPurchaseAgreement
|
390261 | shares |
| CY2013 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
1600219 | shares |
| CY2013 | cmxi |
Stock Issued During Period Shares Issued For Release Of Security Interest In Patents
StockIssuedDuringPeriodSharesIssuedForReleaseOfSecurityInterestInPatents
|
250000 | shares |
| CY2013 | cmxi |
Stock Issued During Period Pursuant To Reorganization Plan
StockIssuedDuringPeriodPursuantToReorganizationPlan
|
27000 | shares |
| CY2012 | cmxi |
Common Stock Issued In Lieu Of Cash For Consultant
CommonStockIssuedInLieuOfCashForConsultant
|
17500 | shares |
| CY2013 | cmxi |
Common Stock Issued In Lieu Of Cash For Consultant
CommonStockIssuedInLieuOfCashForConsultant
|
37500 | shares |
| CY2012 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
38272094 | shares |
| CY2013 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
13356469 | shares |
| CY2013 | cmxi |
Proceeds From Issuance Of Shares In Registered Direct Offering
ProceedsFromIssuanceOfSharesInRegisteredDirectOffering
|
-4557188 | USD |
| CY2012 | cmxi |
Proceeds From Issuance Of Shares On Equity Purchase Agreement
ProceedsFromIssuanceOfSharesOnEquityPurchaseAgreement
|
-4493902 | USD |
| CY2013 | cmxi |
Proceeds From Issuance Of Shares On Equity Purchase Agreement
ProceedsFromIssuanceOfSharesOnEquityPurchaseAgreement
|
-303000 | USD |
| CY2013 | cmxi |
Proceeds From Issuance Of Shares On Equity Purchase Agreement One
ProceedsFromIssuanceOfSharesOnEquityPurchaseAgreementOne
|
-601944 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
13560862 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
5462132 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
35602 | shares |
| CY2012 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
15185 | USD |
| CY2012 | cmxi |
Shares Issued During Period In Lieu Of Dividends
SharesIssuedDuringPeriodInLieuOfDividends
|
76461 | shares |
| CY2012 | cmxi |
Stock Issued During Period On Private Offering
StockIssuedDuringPeriodOnPrivateOffering
|
4231192 | shares |
| CY2012Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
5288256 | shares |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2271500 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1038000 | shares |
| CY2013Q1 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
5000000 | USD |
| CY2013Q1 | us-gaap |
Share Price
SharePrice
|
0.55 | |
| CY2013Q1 | cmxi |
Stock Issued During Period Shares Investors
StockIssuedDuringPeriodSharesInvestors
|
9090911 | shares |
| CY2012Q1 | cmxi |
Convertible Preferred Stock Redeemable Percentage
ConvertiblePreferredStockRedeemablePercentage
|
0.000001 | pure |
| CY2013 | cmxi |
Class Of Warrant Or Right Remaining Exercise Term
ClassOfWarrantOrRightRemainingExerciseTerm
|
P7Y6M | |
| CY2012Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
1.18 | |
| CY2012Q1 | cmxi |
Value Of Warrant Exercise Agreements
ValueOfWarrantExerciseAgreements
|
2800000 | USD |
| CY2013 | cmxi |
Percentage Of Warrants Vested One
PercentageOfWarrantsVestedOne
|
0.5 | pure |
| CY2012Q2 | cmxi |
Percentage Of Warrant Vest On Issuance
PercentageOfWarrantVestOnIssuance
|
0.3 | pure |
| CY2012Q2 | cmxi |
Percentage Of Warrant Vest On Milestones Acheivement
PercentageOfWarrantVestOnMilestonesAcheivement
|
0.7 | pure |
| CY2012 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
924904 | USD |
| CY2013 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
523927 | USD |
| CY2012 | cmxi |
Stock Issued During Period For Committed Equity Financing Facility
StockIssuedDuringPeriodForCommittedEquityFinancingFacility
|
0 | USD |
| CY2013 | cmxi |
Stock Issued During Period For Committed Equity Financing Facility
StockIssuedDuringPeriodForCommittedEquityFinancingFacility
|
204015 | USD |
| CY2012 | cmxi |
Warrants Issued For Loan Modification
WarrantsIssuedForLoanModification
|
0 | USD |
| CY2013 | cmxi |
Warrants Issued For Loan Modification
WarrantsIssuedForLoanModification
|
151758 | USD |
| CY2012 | cmxi |
Warrants Issued For Term Loan
WarrantsIssuedForTermLoan
|
0 | USD |
| CY2013 | cmxi |
Warrants Issued For Term Loan
WarrantsIssuedForTermLoan
|
568324 | USD |
| CY2012 | cmxi |
Common Stock And Warrants Issued For Release Of Security Interest In Patents
CommonStockAndWarrantsIssuedForReleaseOfSecurityInterestInPatents
|
0 | USD |
| CY2013 | cmxi |
Common Stock And Warrants Issued For Release Of Security Interest In Patents
CommonStockAndWarrantsIssuedForReleaseOfSecurityInterestInPatents
|
325693 | USD |
| CY2012 | cmxi |
Warrants Issued To Investors
WarrantsIssuedToInvestors
|
0 | USD |
| CY2013 | cmxi |
Warrants Issued To Investors
WarrantsIssuedToInvestors
|
17850 | USD |
| CY2012 | cmxi |
Warrants Issued To Placement Agents
WarrantsIssuedToPlacementAgents
|
0 | USD |
| CY2013 | cmxi |
Warrants Issued To Placement Agents
WarrantsIssuedToPlacementAgents
|
39150 | USD |
| CY2012 | cmxi |
Stock Issued During Period Value In Lieu Of Dividends
StockIssuedDuringPeriodValueInLieuOfDividends
|
82500 | USD |
| CY2013 | cmxi |
Stock Issued During Period Value In Lieu Of Dividends
StockIssuedDuringPeriodValueInLieuOfDividends
|
0 | USD |
| CY2012 | cmxi |
Derivative Liability For Embedded Conversion Option
DerivativeLiabilityForEmbeddedConversionOption
|
0 | USD |
| CY2012Q4 | us-gaap |
Convertible Debt
ConvertibleDebt
|
462815 | USD |
| CY2013 | cmxi |
Derivative Liability For Embedded Conversion Option
DerivativeLiabilityForEmbeddedConversionOption
|
965484 | USD |
| CY2012Q4 | cmxi |
Issuance Of Contingent Consideration
IssuanceOfContingentConsideration
|
11109020 | USD |
| CY2013Q4 | cmxi |
Issuance Of Contingent Consideration
IssuanceOfContingentConsideration
|
0 | USD |
| CY2012 | cmxi |
Business Combination Replacement Warrant Issued
BusinessCombinationReplacementWarrantIssued
|
1883751 | USD |
| CY2013 | cmxi |
Business Combination Replacement Warrant Issued
BusinessCombinationReplacementWarrantIssued
|
0 | USD |
| CY2012 | cmxi |
Shares Issued During Period In Lieu Of Subscription Receivable
SharesIssuedDuringPeriodInLieuOfSubscriptionReceivable
|
2790107 | USD |
| CY2013 | cmxi |
Shares Issued During Period In Lieu Of Subscription Receivable
SharesIssuedDuringPeriodInLieuOfSubscriptionReceivable
|
0 | USD |
| CY2012 | cmxi |
Effect Of Cancellation Of Escrowed Shares
EffectOfCancellationOfEscrowedShares
|
195132 | USD |
| CY2013 | cmxi |
Effect Of Cancellation Of Escrowed Shares
EffectOfCancellationOfEscrowedShares
|
0 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
30000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
0 | USD |
| CY2012 | us-gaap |
Interest Paid
InterestPaid
|
342000 | USD |
| CY2013 | us-gaap |
Interest Paid
InterestPaid
|
564000 | USD |
| CY2013Q4 | cmxi |
Research And Development
ResearchAndDevelopment
|
368000 | USD |
| CY2009Q3 | cmxi |
Letter Of Credit
LetterOfCredit
|
50000 | USD |
| CY2013 | cmxi |
Deposit Interest Rate
DepositInterestRate
|
0.0010 | pure |
| CY2013 | cmxi |
Shares Issuable Contingent Condition Description
SharesIssuableContingentConditionDescription
|
This exchange was contingent on the Companys attaining aggregate gross revenues for four consecutive quarters of at least $10,000,000 and if met would result in the issuance of 325,000 shares of the Companys Common stock. | |
| CY2013 | cmxi |
Contingently Issuable Shares
ContingentlyIssuableShares
|
325000 | shares |
| CY2012Q2 | cmxi |
Contingently Issuable Shares Amount
ContingentlyIssuableSharesAmount
|
471000 | USD |
| CY2013 | cmxi |
Business Acquisitions Contingent Consideration Shares Issuable
BusinessAcquisitionsContingentConsiderationSharesIssuable
|
20309723 | shares |
| CY2013Q1 | cmxi |
Operating Expense Recognized Value
OperatingExpenseRecognizedValue
|
1006000 | USD |
| CY2012 | cmxi |
Acquisition Costs Business Acquisition
AcquisitionCostsBusinessAcquisition
|
528000 | USD |
| CY2013 | us-gaap |
Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
|
18760610 | USD |
| CY2013 | cmxi |
Business Combination Contingent Consideration At Fair Value Noncurrent
BusinessCombinationContingentConsiderationAtFairValueNoncurrent
|
11109020 | USD |
| CY2013 | cmxi |
Business Combination Cost Of Acquired Entity Replacement Warrant
BusinessCombinationCostOfAcquiredEntityReplacementWarrant
|
1883751 | USD |
| CY2013 | us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
31753381 | USD |
| CY2013Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
|
24563 | USD |
| CY2013Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
|
35394 | USD |
| CY2013Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
|
772486 | USD |
| CY2013Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
|
87391 | USD |
| CY2013Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
|
1044530 | USD |
| CY2013Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
|
118617 | USD |
| CY2013Q4 | cmxi |
Business Acquisition Purchase Price Allocation Goodwill
BusinessAcquisitionPurchasePriceAllocationGoodwill
|
421694 | USD |
| CY2013Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
|
31753381 | USD |
| CY2013 | dei |
Document Type
DocumentType
|
10-K | |
| CY2013 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2013 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | |
| CY2013 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
| CY2013 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2013 | dei |
Trading Symbol
TradingSymbol
|
CMXI | |
| CY2014Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
110751077 | shares |
| CY2013 | dei |
Entity Registrant Name
EntityRegistrantName
|
CYTOMEDIX INC | |
| CY2013 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001091596 | |
| CY2013 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2013 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2013 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2013Q2 | dei |
Entity Public Float
EntityPublicFloat
|
36000000 | USD |
| CY2012Q4 | us-gaap |
Customer Deposits Current
CustomerDepositsCurrent
|
0 | USD |
| CY2013Q4 | us-gaap |
Customer Deposits Current
CustomerDepositsCurrent
|
1795803 | USD |
| CY2011Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
19700000 | USD |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.002 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.122 | pure |
| CY2013Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
1733055 | USD |
| CY2013 | cmxi |
Other Issuance Of Common Stock
OtherIssuanceOfCommonStock
|
10578 | shares |
| CY2013Q4 | us-gaap |
Convertible Debt
ConvertibleDebt
|
202658 | USD |
| CY2012 | cmxi |
Business Acquisition Purchases Price Allocation Goodwill Amount
BusinessAcquisitionPurchasesPriceAllocationGoodwillAmount
|
616826 | USD |
| cmxi |
Intangible Asset Carrying Value
IntangibleAssetCarryingValue
|
1700000 | USD | |
| CY2013 | us-gaap |
Excise And Sales Taxes
ExciseAndSalesTaxes
|
185767 | USD |
| CY2012 | cmxi |
Noncash Or Part Noncash Acquisition Effect Of Modification Of Convertible Debt
NoncashOrPartNoncashAcquisitionEffectOfModificationOfConvertibleDebt
|
0 | USD |
| CY2013 | cmxi |
Noncash Or Part Noncash Acquisition Effect Of Modification Of Convertible Debt
NoncashOrPartNoncashAcquisitionEffectOfModificationOfConvertibleDebt
|
151032 | USD |
| CY2012 | cmxi |
Debt Conversion Converted Instrument Warrants Issued
DebtConversionConvertedInstrumentWarrantsIssued
|
0 | USD |
| CY2013 | cmxi |
Debt Conversion Converted Instrument Warrants Issued
DebtConversionConvertedInstrumentWarrantsIssued
|
1353842 | USD |
| CY2013Q4 | cmxi |
Changes In Fair Value Warrants
ChangesInFairValueWarrants
|
12000 | USD |
| CY2013Q4 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
2250000 | USD |
| CY2013Q4 | cmxi |
Gross Proceeds From Convertible Notes And Stock Warrants
GrossProceedsFromConvertibleNotesAndStockWarrants
|
3000000 | USD |
| CY2013 | cmxi |
Debt Discount Conversion Of Options And Warrants
DebtDiscountConversionOfOptionsAndWarrants
|
2250000 | USD |
| CY2013 | cmxi |
Warrants Issued During Period Value To Placement Agent
WarrantsIssuedDuringPeriodValueToPlacementAgent
|
69000 | USD |
| CY2013 | cmxi |
Adjustments To Additional Paid In Capital Warrant Issued For Credit And Security Agreement
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForCreditAndSecurityAgreement
|
580394 | USD |
| CY2013 | cmxi |
Adjustments To Additional Paid In Capital Warrants Issued For Term Loan Modification
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedForTermLoanModification
|
455275 | USD |
| CY2013 | cmxi |
Stock Issued During Period Value For Release Of Security Interest In Patents
StockIssuedDuringPeriodValueForReleaseOfSecurityInterestInPatents
|
325693 | USD |
| CY2013 | cmxi |
Stock Issued During Period Value Pursuant To Equity Purchase Agreements Executed
StockIssuedDuringPeriodValuePursuantToEquityPurchaseAgreementsExecuted
|
601945 | USD |
| CY2013 | cmxi |
Stock Issued During Period Value To Holder Of Prebankruptcy Series Preferred Stock Pursuant To Reorganization Plan
StockIssuedDuringPeriodValueToHolderOfPrebankruptcySeriesPreferredStockPursuantToReorganizationPlan
|
0 | USD |
| CY2013 | cmxi |
Compensation Cost Recognition Period
CompensationCostRecognitionPeriod
|
P1M6D | |
| CY2013 | cmxi |
Stock Issued During Period Value For Other Corrections
StockIssuedDuringPeriodValueForOtherCorrections
|
-1 | USD |
| CY2013 | cmxi |
Adjustments To Additional Paid In Capital Amendment To Contingent Consideration For Aldagen Acquisition
AdjustmentsToAdditionalPaidInCapitalAmendmentToContingentConsiderationForAldagenAcquisition
|
1006159 | USD |
| CY2013 | cmxi |
Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Foreign Countries Percentage
EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountriesPercentage
|
0.91 | pure |
| CY2013 | cmxi |
Medical Device Excise Tax Percentage
MedicalDeviceExciseTaxPercentage
|
0.023 | pure |
| CY2012 | cmxi |
Costs Of Depreciation And Amortization
CostsOfDepreciationAndAmortization
|
823404 | USD |
| CY2013 | cmxi |
Costs Of Depreciation And Amortization
CostsOfDepreciationAndAmortization
|
726000 | USD |
| CY2013Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill Fair Value Disclosure
IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure
|
1500000 | USD |
